Horizon Discovery has established new Centers of Excellence (CoEs) for gene editing at the Gurdon Institute, Cambridge University with Prof. Steve Jackson FRS, and the Cambridge Institute for Medical Research with Prof. David Rubinsztein.   Prof. Jackson will work with Horizon’s rAAV genome editing technology (GENESIS) to generate isogenic cell models of cancer focused on specific gene mutations involved in DNA repair and DNA damage signaling and their relationship to cancer progression.   Prof....